Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer

por Tsang, R Y, Finn, R S
Publicado 2012

Cell differentiation and dominant signaling pathway signatures in the molecular classification of human breast cancer cell lines

por Wilson, CA, Dering, J, Bernardo, G, Rong, HM, Ginther, C, Ferdman, R, Cook, AM, Finn, R, Slamon, DJ
Publicado 2005

KRAS mutational subtype and copy number predict in vitro response of human pancreatic cancer cell lines to MEK inhibition

por Hamidi, H, Lu, M, Chau, K, Anderson, L, Fejzo, M, Ginther, C, Linnartz, R, Zubel, A, Slamon, D J, Finn, R S
Publicado 2014

(18)F-Fluciclovine ((18)F-FACBC) PET imaging of recurrent brain tumors

por Michaud, Laure, Beattie, B. J., Akhurst, T., Dunphy, M., Zanzonico, P., Finn, R., Mauguen, A., Schöder, H., Weber, W. A., Lassman, A. B., Blasberg, R.
Publicado 2019

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells

por Konecny, G E, Venkatesan, N, Yang, G, Dering, J, Ginther, C, Finn, R, Rahmeh, M, Fejzo, M Schoenberg, Toft, D, Jiang, S-W, Slamon, D J, Podratz, K C
Publicado 2008

Activity of the multikinase inhibitor dasatinib against ovarian cancer cells

por Konecny, G E, Glas, R, Dering, J, Manivong, K, Qi, J, Finn, R S, Yang, G R, Hong, K-L, Ginther, C, Winterhoff, B, Gao, G, Brugge, J, Slamon, D J
Publicado 2009

Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial

por Rugo, H S, Diéras, V, Gelmon, K A, Finn, R S, Slamon, D J, Martin, M, Neven, P, Shparyk, Y, Mori, A, Lu, D R, Bhattacharyya, H, Bartlett, C Huang, Iyer, S, Johnston, S, Ettl, J, Harbeck, N
Publicado 2018

Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up

por Rugo, H. S., Finn, R. S., Diéras, V., Ettl, J., Lipatov, O., Joy, A. A., Harbeck, N., Castrellon, A., Iyer, S., Lu, D. R., Mori, A., Gauthier, E. R., Bartlett, C. Huang, Gelmon, K. A., Slamon, D. J.
Publicado 2019

Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases

por Turner, N C, Finn, R S, Martin, M, Im, S -A, DeMichele, A, Ettl, J, Diéras, V, Moulder, S, Lipatov, O, Colleoni, M, Cristofanilli, M, Lu, D R, Mori, A, Giorgetti, C, Iyer, S, Bartlett, C Huang, Gelmon, K A
Publicado 2018